Quick release compositions
US6416787B1 · kind B1 · utility
0Cited by
4References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 28, 2000 |
| Grant date | Jul 9, 2002 |
| Priority date | — |
| Expiry date | Feb 28, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/1664
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A dosage form comprises a porous extrudate. The extrudate is obtained by extruding, at elevated temperature, a composition comprising a starch, water, a thermostable enzyme, and a pharmaceutically active agent. The porous extrudate is capable of disintegration when exposed to an aqueous environment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.